Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 1997

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

paclitaxel

Trial Locations (18)

12209

Women's Health Center at Albany Medical Center, Albany

33401

Good Samaritan Medical Center, West Palm Beach

36608

Oncology Center at Providence Park, Mobile

37203

Brookview Research, Inc., Nashville

44195

Cleveland Clinic Cancer Center, Cleveland

44302

Akron General Medical Center, Akron

45219

Oncology/Hematology Care, Inc., Cincinnati

62526

Decatur Memorial Hospital Cancer Care Institute, Decatur

72703

Highlands Oncology Group, P.A., Fayetteville

79106

Harrington Cancer Center, Amarillo

85013

Hematology Associates, Ltd., Phoenix

93105

Cancer Center of Santa Barbara, Santa Barbara

99202

Rockwood Clinic P.S., Spokane

68131-2197

Creighton University Cancer Center, Omaha

07753

Jersey Shore Cancer Center, Neptune City

28232-2861

Carolinas Medical Center, Charlotte

17105-8700

Women's Cancer Center of Central PA, P.C., Harrisburg

02905

Women and Infants Hospital of Rhode Island, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theradex

INDUSTRY